General Information of the Compound
Compound ID
CP0046151
Compound Name
2-(6-(piperazin-1-yl)pyrimidin-4-ylamino)thiazole-5-carbonitrile
    Show/Hide
Structure
Formula
C12H13N7S
Molecular Weight
287.352
Canonical SMILES
N#Cc1cnc(Nc2cc(ncn2)N2CCNCC2)s1
    Show/Hide
InChI
InChI=1S/C12H13N7S/c13-6-9-7-15-12(20-9)18-10-5-11(17-8-16-10)19-3-1-14-2-4-19/h5,7-8,14H,1-4H2,(H,15,16,17,18)
    Show/Hide
InChIKey
LTSAIVCADIPFKF-UHFFFAOYSA-N
Physicochemical Property
logP
0.95798
Rotatable Bonds
3
Heavy Atom Count
20
Polar Areas
89.76
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21934630
ChEMBL ID
CHEMBL380944
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00864, Vascular endothelial growth factor receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 34 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 16 nM